You’re offline. This is a read only version of the page.
Toggle navigation
Research Registry
Research Registry
Browse the Research Registry
Search the Research Registry
Useful links
Useful links
Public Data Browser
Support for grant applications
PanelApp
Research Management Twitter
Research Environment User Guide
Research Environment videos
Research Environment Training Sessions
News
Help
Help
Service Desk
Research Environment User Guide
For the public
All
All
Web Pages
Search Filter
All
Web Pages
Search
Sign in
Research Portal
Home
Research Registry
Browse the Research R...
Browse the research registry public
Browse the research registry
In this section
Browse the Research Registry
Search the Research Registry
Research registry ID
Date submitted
Project lead
Title
Validation and optimisation of genomic prevention tools
Community 1
Community 2
Community 3
Description of Research: Objectives, benefits and
Our research will involve evaluating the performance of polygenic risk scores (PRSs) in the Genomics England cohort, and then optimising these PRSs using additional data. PRSs are a way of combining information from a person’s genome to create a single score that can be used to predict that person’s risk of getting a disease. In the evaluation stage, PRSs that have been constructed using data from outside the Genomics England cohort will be calculated on individuals in the Genomics England cohort, and then compared against their known disease status to evaluate their predictive power. In the optimisation stage, genomewide association statistics will be calculated on some individuals both with and without a given disease in the Genomics England cohort. These statistics, which are aggregated and represent group-level rather than individual-level information, will then be used to improve the predictive power of the PRSs.
Lay summary
Our research will involve evaluating the performance of polygenic risk scores (PRSs) in the Genomics England cohort, and then optimising these PRSs using additional data. PRSs are a way of combining information from a person’s genome to create a single score that can be used to predict that person’s risk of getting a disease. In the evaluation stage, PRSs that have been constructed using data from outside the Genomics England cohort will be calculated on individuals in the Genomics England cohort, and then compared against their known disease status to evaluate their predictive power. In the optimisation stage, genomewide association statistics will be calculated on some individuals both with and without a given disease in the Genomics England cohort. These statistics, which are aggregated and represent group-level rather than individual-level information, will then be used to improve the predictive power of the PRSs.
Patient and Public Involvement and Engagement
Support and data requirements
What are your compute requirements?
Collaborations envisaged
Publication of findings